Experimental passage of FMDV leads to positive selection of amino acid replacements in capsid-coding regions, increasing viral infectivity under restrictive conditions.
No takes yet. Share an insight, caveat, or question.
Highlights need for FMDV antigenic surveillance; leaves open whether sites predict vaccine escape in the field.
Fares et al. (2001) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: